PDLI Related Earnings
-
PDL BioPharma, Inc. (PDLI) Tops Q1 EPS by 1c
-
PDL BioPharma, Inc. (PDLI) Tops Q4 EPS 2c
-
PDL BioPharma, Inc. (PDLI) Tops Q3 EPS by 2c
-
PDL BioPharma, Inc. (PDLI) Tops Q2 EPS by 4c
-
PDL BioPharma, Inc. (PDLI) Reports In-Line Q4 EPS
-
PDL BioPharma, Inc. (PDLI) Tops Q3 EPS by 1c, Sales Beat Expectations
-
PDL BioPharma, Inc. (PDLI) Misses Q2 EPS by 1c
-
PDL BioPharma, Inc. (PDLI) Tops Q1 EPS by 1c
-
PDL BioPharma, Inc. (PDLI) Misses Q4 EPS Views
-
PDL BioPharma (PDLI) Posts Q3 EPS of $0.24, Shy by 1c
-
PDL BioPharma (PDLI) Reports Q2 EPS of $0.30, Misses by 8c
-
PDL BioPharma (PDLI) Misses Street's Q1 Views
-
PDL BioPharma (PDLI) Posts Q4 EPS of $0.17, Tops by 2c; Guides Q110 Sales Below Street
-
PDL BioPharma (PDLI) Reports Q4 EPS of $0.17, Misses by 2c
-
PDL BioPharma (PDLI) Reports Q4 Revenues
-
PDL BioPharma (PDLI) Reports Mixed Q3 Results; Narrows FY09 Sales Guidance
-
PDL BioPharma (PDLI) Tops Q2 Views
-
PDL BioPharma (PDLI) Reports Mixed Q1 Results; Re-affirms
-
PDL BioPharma (PDLI) Reports Q4 EPS of $0.26; Declares Two Qtr. Dividends of $0.50/Share
-
PDL BioPharma (PDLI) Misses Q3 View
-
PDL BioPharma (PDLI) Tops Q2 View
-
PDL BioPharma (PDLI) Misses Q4 EPS, Revs Light
-
PDL BioPharma (PDLI) Reports Q3 EPS of $0.16; Suspends Guidance for FY07
-
PDL BioPharma (PDLI) Misses Q1 EPS by 3c; Guides
-
PDL BioPharma (PDLI) Reports Q4 Adj EPS of $0.05
-
PDL BioPharma (PDLI) Reports Q3 Results; Guide
-
PDL BioPharma (PDLI) Reports Q2 EPS of $0.18
-
PDL BioPharma (PDLI) Misses Q1 EPS by 12c, Guides For Full-Year
-
PDLI Tops Q4 EPS; Guides
-
PDL BioPharma-PDLI March option implied volatility increases to 48 prior to EPS
-
PDLI Reported a Q3 Loss; Guides
-
Earnings to Watch After the Close: CEPH, EDS, ERTS, PNRA, SUNW, SYMC
-
PDLI Beat Q2 EPS by 4 Cents
-
PDLI Reported a Q1 Loss
-
PDLI Reported a Q4 Loss
Back to PDLI Stock Lookup
